antiviral compound (Lilly)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantiviral compound (Lilly)
Drug Alias NameHIV therapy (Lilly)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleotide reverse transcriptase inhibitors
TargetsNucleotide reverse transcriptase
Therapy Area/IndicationsVirus DiseasesHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsVirus DiseasesHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A